Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript March 12, 2026
Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.06413 EPS, expectations were $0.035.
Operator: Good day, and welcome to the Fourth Quarter and Full Year 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Taylor Krafchik, Senior Vice President at Ellipsis TA. Please...
